SCHEMBL16398554

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL18004391	0.91	QPCT (0.33)	MRGPRX4QPCT
	SCHEMBL18004157	0.90	QPCT (0.33)	MRGPRX4QPCT
	SCHEMBL18004163	0.88	QPCT (0.32)	QPCTAR
	SCHEMBL18004250	0.86	QPCT (0.36)	MRGPRX4QPCT
	SCHEMBL18003935	0.86	CNR1 (0.35)	MRGPRX4
	SCHEMBL18004373	0.85	CTSS (0.36)	MRGPRX4QPCT
	SCHEMBL18004241	0.83	HTT (0.38)	MRGPRX4
	SCHEMBL18004707	0.83	MRGPRX4 (0.40)	MRGPRX4
	SCHEMBL18004327	0.83	NR1H2 (0.40)	MRGPRX4QPCT
	SCHEMBL18004347	0.83	CTSS (0.34)	MRGPRX4AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.